Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BioAtla, Inc.BCAB · Entity 879 | Director · Chief Executive Officer | August 31, 2026 | September 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BioAtla, Inc.
Report date August 31, 2026 · Filed September 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 52,035 |
Reported balance
After 2026-08-31 transaction · row 1
1 source rowRow 1 · 2026-08-31 · Tax withholding · Disposed 259 · Balance 52,035 F1: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. |
| Common StockSEC Table I · non-derivative | IndirectBy Spouse | 15,870 |
Reported balance
Holding disclosure · report date 2026-08-31 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 15,870 |
| Common StockSEC Table I · non-derivative | IndirectBy Carolyn Short 2020 Irrevocable Gift Trust | 5,174 |
Reported balance
Holding disclosure · report date 2026-08-31 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 5,174 |
| Common StockSEC Table I · non-derivative | IndirectBy Jay Short 2020 Irrevocable Gift Trust | 5,174 |
Reported balance
Holding disclosure · report date 2026-08-31 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 5,174 |
| Common StockSEC Table I · non-derivative | IndirectBy Capia IP, LLC | 6,046 |
Reported balance
Holding disclosure · report date 2026-08-31 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 6,046 |
| Common StockSEC Table I · non-derivative | IndirectBy Himalaya Parent LLC | 1 |
Reported balance
Holding disclosure · report date 2026-08-31 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 1 F2: The Reporting Person and his spouse are the managers of Himalaya Parent LLC and collectively make investment decisions on the behalf of the entity. The Reporting Person and his spouse disclaim beneficial ownership of the reported securities except to the extent of his or her pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units.
F2: The Reporting Person and his spouse are the managers of Himalaya Parent LLC and collectively make investment decisions on the behalf of the entity. The Reporting Person and his spouse disclaim beneficial ownership of the reported securities except to the extent of his or her pecuniary interest therein.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 31, 2026 Filed Sep 2, 2026 21:27 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 259 | $1.69 | $437.71 |
DisclosureSEC source: 0001193125-26-380482 · ownership.xml · nonDerivative · entry 1 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,035 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| May 31, 2026 Filed Jun 5, 2026 20:30 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 259 | $3.93 | $1,017.87 |
DisclosureSEC source: 0001193125-26-259702 · ownership.xml · nonDerivative · entry 2 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,294 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. F2 · balance_after: Effective on April 6, 2026, the Issuer effected a 50-for-1 share consolidation of its common stock (the "Share Consolidation"). The amount of securities reported on this Form 4 has been adjusted to reflect the Share Consolidation. Read SEC document |
| March 12, 2026 Filed Jun 5, 2026 20:30 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 639 | $0.17 | $107.35 |
DisclosureSEC source: 0001193125-26-259702 · ownership.xml · nonDerivative · entry 1 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,553 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. F2 · balance_after: Effective on April 6, 2026, the Issuer effected a 50-for-1 share consolidation of its common stock (the "Share Consolidation"). The amount of securities reported on this Form 4 has been adjusted to reflect the Share Consolidation. Read SEC document |
| March 11, 2026 Filed Mar 12, 2026 20:07 UTC | BioAtla, Inc. BCAB · Entity 879 | GrantCommon Stock | 430,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-104134 · ownership.xml · nonDerivative · entry 1 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,659,603 F1 · shares: Represents shares of Common Stock underlying a time-based restricted stock unit award ("RSU"). The RSU will vest as to 25% of the total number of shares on March 11, 2027, and thereafter, 6.25% of the total number of shares subject to the RSU shall vest on the last day of each May, August, November and February, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| February 28, 2026 Filed Mar 2, 2026 23:14 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 7,728 | $0.25 | $1,908.82 |
DisclosureSEC source: 0001193125-26-085971 · ownership.xml · nonDerivative · entry 1 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,229,603 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| November 30, 2025 Filed Dec 1, 2025 23:35 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 6,347 | $0.90 | $5,737.69 |
DisclosureSEC source: 0001193125-25-304171 · ownership.xml · nonDerivative · entry 1 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,237,331 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| August 31, 2025 Filed Sep 2, 2025 23:09 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 6,347 | $0.46 | $2,891.06 |
DisclosureSEC source: 0000950170-25-112618 · ownership.xml · nonDerivative · entry 1 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,243,678 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| May 31, 2025 Filed Jun 3, 2025 20:31 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 6,347 | $0.41 | $2,595.92 |
DisclosureSEC source: 0000950170-25-080994 · ownership.xml · nonDerivative · entry 1 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,250,025 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| March 12, 2025 Filed Mar 13, 2025 20:12 UTC | BioAtla, Inc. BCAB · Entity 879 | GrantCommon Stock | 431,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-038746 · ownership.xml · nonDerivative · entry 1 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,256,372 F1 · shares: Represents shares of Common Stock underlying a time-based restricted stock unit award ("RSU"). The RSU will vest as to 25% of the total number of shares on March 11, 2026, and thereafter, 6.25% of the total number of shares subject to the RSU shall vest on the last day of each May, August, November and February so long as the reporting person remains a service provider. Read SEC document |
| February 16, 2025 Filed Feb 25, 2025 01:31 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 30,911 | $0.46 | $14,219.06 |
DisclosureSEC source: 0000950170-25-025969 · ownership.xml · nonDerivative · entry 1 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,825,372 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| February 16, 2024 Filed Feb 20, 2024 21:19 UTC | BioAtla, Inc. BCAB · Entity 879 | GrantCommon Stock | 417,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-003507 · doc4.xml · nonDerivative · entry 1 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,856,283 F1 · shares: Represents shares of Common Stock underlying a time-based restricted stock unit award ("RSU"). The RSU will vest as to 25% of the total number of shares on February 16, 2025, and the remainder in equal quarterly installments over the three years thereafter, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| December 20, 2023 Filed Dec 20, 2023 23:27 UTC | BioAtla, Inc. BCAB · Entity 879 | PurchaseCommon Stock | 50,000 | $2.14 | $106,910.00 |
DisclosureSEC source: 0001209191-23-059387 · doc4.xml · nonDerivative · entry 1 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,439,283 F1 · price: The range of prices for the shares of Common Stock is from $2.02 to $2.215. The Reporting Person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price. Read SEC document |
| October 31, 2023 Filed Nov 2, 2023 16:28 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 2,888 | $1.47 | $4,245.36 |
DisclosureSEC source: 0001209191-23-054075 · doc4.xml · nonDerivative · entry 1 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,389,283 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| September 30, 2023 Filed Oct 2, 2023 22:07 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 2,888 | $1.70 | $4,909.60 |
DisclosureSEC source: 0001209191-23-051187 · doc4.xml · nonDerivative · entry 1 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,392,171 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| August 31, 2023 Filed Sep 2, 2023 00:01 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 2,888 | $2.51 | $7,248.88 |
DisclosureSEC source: 0001209191-23-048031 · doc4.xml · nonDerivative · entry 1 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,395,059 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| July 31, 2023 Filed Aug 1, 2023 21:44 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 2,888 | $2.99 | $8,635.12 |
DisclosureSEC source: 0001209191-23-044052 · doc4.xml · nonDerivative · entry 1 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,397,947 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| June 30, 2023 Filed Jul 3, 2023 21:45 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 2,888 | $3.00 | $8,664.00 |
DisclosureSEC source: 0001209191-23-040669 · doc4.xml · nonDerivative · entry 1 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,400,835 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 00:26 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 2,888 | $3.15 | $9,097.20 |
DisclosureSEC source: 0001209191-23-033473 · doc4.xml · nonDerivative · entry 1 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,403,723 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| April 30, 2023 Filed May 2, 2023 22:04 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 2,888 | $3.37 | $9,732.56 |
DisclosureSEC source: 0001209191-23-026662 · doc4.xml · nonDerivative · entry 1 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,406,611 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 00:04 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 2,888 | $2.68 | $7,739.84 |
DisclosureSEC source: 0001209191-23-022431 · doc4.xml · nonDerivative · entry 1 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,409,499 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| March 29, 2023 Filed Mar 30, 2023 23:17 UTC | BioAtla, Inc. BCAB · Entity 879 | PurchaseCommon Stock | 40,800 | $2.47 | $100,861.68 |
DisclosureSEC source: 0001209191-23-021720 · doc4.xml · nonDerivative · entry 1 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,412,387 F1 · price: The range of prices for the shares of Common Stock is from $2.45 to $2.50. The Reporting Person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 23:34 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 2,888 | $2.89 | $8,346.32 |
DisclosureSEC source: 0001209191-23-014295 · doc4.xml · nonDerivative · entry 1 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,371,587 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| February 10, 2023 Filed Mar 1, 2023 23:34 UTC | BioAtla, Inc. BCAB · Entity 879 | GrantEmployee Stock Option (right to buy) · Derivative | 850,000 | $0.00 Strike: $3.65 | $0.00 |
DisclosureSEC source: 0001209191-23-014295 · doc4.xml · derivative · entry 7 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 850,000 Underlying: Common Stock · 850,000 shares Expires 2033-02-10 F3 · derivative.exercise_date: The option vests over a period of four years, with 25% of the shares underlying the option vesting on the first anniversary of the date of grant, and the remainder vesting in 36 substantially equal monthly installments thereafter, subject to the reporting person's continued service to the company through the applicable vesting dates. Read SEC document |
| January 31, 2023 Filed Feb 3, 2023 00:12 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 3,517 | $3.79 | $13,329.43 |
DisclosureSEC source: 0001209191-23-006438 · doc4.xml · nonDerivative · entry 1 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,374,475 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| December 31, 2022 Filed Jan 3, 2023 22:09 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 4,667 | $8.25 | $38,502.75 |
DisclosureSEC source: 0001209191-23-000323 · doc4.xml · nonDerivative · entry 1 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,377,992 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| November 30, 2022 Filed Dec 2, 2022 02:08 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 4,667 | $11.01 | $51,383.67 |
DisclosureSEC source: 0001209191-22-059271 · doc4.xml · nonDerivative · entry 1 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,382,659 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| October 31, 2022 Filed Nov 1, 2022 23:58 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 3,454 | $6.89 | $23,798.06 |
DisclosureSEC source: 0001209191-22-055169 · doc4.xml · nonDerivative · entry 1 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,387,326 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 23:57 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 2,888 | $7.70 | $22,237.60 |
DisclosureSEC source: 0001209191-22-052567 · doc4.xml · nonDerivative · entry 1 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,390,780 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| August 31, 2022 Filed Sep 1, 2022 22:52 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 2,888 | $8.71 | $25,154.48 |
DisclosureSEC source: 0001209191-22-048367 · doc4.xml · nonDerivative · entry 1 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,393,668 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| August 12, 2022 Filed Aug 15, 2022 20:37 UTC | BioAtla, Inc. BCAB · Entity 879 | PurchaseCommon Stock | 26,350 | $7.84 | $206,599.81 |
DisclosureSEC source: 0001209191-22-045810 · doc4.xml · nonDerivative · entry 1 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,396,556 F1 · price: The range of prices for the shares of Common Stock is from $7.67 to $8.00. The Reporting Person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price. Read SEC document |
| July 31, 2022 Filed Aug 1, 2022 22:31 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 2,888 | $3.40 | $9,819.20 |
DisclosureSEC source: 0001209191-22-043744 · doc4.xml · nonDerivative · entry 1 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,370,206 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| June 30, 2022 Filed Jul 1, 2022 21:26 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 2,888 | $2.85 | $8,230.80 |
DisclosureSEC source: 0001209191-22-040328 · doc4.xml · nonDerivative · entry 1 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,373,094 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| June 22, 2022 Filed Jun 23, 2022 20:59 UTC | BioAtla, Inc. BCAB · Entity 879 | PurchaseCommon Stock | 40,308 | $2.91 | $117,296.28 |
DisclosureSEC source: 0001209191-22-038959 · doc4.xml · nonDerivative · entry 2 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,375,982 F1 · kind: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The range of prices for the shares of Common Stock is from $2.70 to $3.02. The Reporting Person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price. Read SEC document |
| June 21, 2022 Filed Jun 23, 2022 20:59 UTC | BioAtla, Inc. BCAB · Entity 879 | PurchaseCommon Stock | 29,082 | $2.79 | $81,039.90 |
DisclosureSEC source: 0001209191-22-038959 · doc4.xml · nonDerivative · entry 1 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,335,674 F1 · kind: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The range of prices for the shares of Common Stock is from $2.68 to $2.87. The Reporting Person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price. Read SEC document |
| May 31, 2022 Filed Jun 3, 2022 22:15 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 2,888 | $2.41 | $6,960.08 |
DisclosureSEC source: 0001209191-22-034323 · doc4.xml · nonDerivative · entry 2 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,306,592 F2 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| April 30, 2022 Filed May 6, 2022 20:55 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 2,888 | $3.48 | $10,050.24 |
DisclosureSEC source: 0001209191-22-027626 · doc4.xml · nonDerivative · entry 1 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,304,102 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| March 31, 2022 Filed Apr 5, 2022 01:12 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 2,888 | $5.00 | $14,440.00 |
DisclosureSEC source: 0001209191-22-022741 · doc4.xml · nonDerivative · entry 1 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,306,990 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| February 28, 2022 Filed Mar 4, 2022 22:00 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 2,888 | $6.48 | $18,714.24 |
DisclosureSEC source: 0001209191-22-016353 · doc4.xml · nonDerivative · entry 1 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,309,878 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 02:20 UTC | BioAtla, Inc. BCAB · Entity 879 | GrantEmployee Stock Option (right to buy) · Derivative | 337,000 | $0.00 Strike: $6.66 | $0.00 |
DisclosureSEC source: 0001209191-22-012944 · doc4.xml · derivative · entry 1 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 337,000 Underlying: Common Stock · 337,000 shares Expires 2032-02-22 F1 · derivative.exercise_date: The option vests over a period of four years, with 25% of the shares underlying the option vesting on February 22, 2023, the first anniversary of the date of grant, and the remainder vesting in 36 substantially equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting dates. Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 22:39 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 3,378 | $9.56 | $32,293.68 |
DisclosureSEC source: 0001209191-22-006493 · doc4.xml · nonDerivative · entry 1 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,312,766 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| December 31, 2021 Filed Jan 6, 2022 01:30 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 4,667 | $19.63 | $91,613.21 |
DisclosureSEC source: 0001209191-22-002038 · doc4.xml · nonDerivative · entry 1 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,316,144 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| December 02, 2021 Filed Dec 7, 2021 22:40 UTC | BioAtla, Inc. BCAB · Entity 879 | SaleCommon Stock | 96 | $22.47 | $2,157.22 |
DisclosureSEC source: 0001209191-21-068383 · doc4.xml · nonDerivative · entry 8 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,320,811 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F9 · price: The range of prices for the shares of Common Stock is from $22.40 to $22.51. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| December 02, 2021 Filed Dec 7, 2021 22:40 UTC | BioAtla, Inc. BCAB · Entity 879 | SaleCommon Stock | 4,715 | $21.74 | $102,508.82 |
DisclosureSEC source: 0001209191-21-068383 · doc4.xml · nonDerivative · entry 7 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,320,907 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F8 · price: The range of prices for the shares of Common Stock is from $21.40 to $22.37. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| December 01, 2021 Filed Dec 7, 2021 22:40 UTC | BioAtla, Inc. BCAB · Entity 879 | SaleCommon Stock | 2,953 | $24.22 | $71,533.47 |
DisclosureSEC source: 0001209191-21-068383 · doc4.xml · nonDerivative · entry 6 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,325,622 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F7 · price: The range of prices for the shares of Common Stock is from $23.80 to $24.68. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| December 01, 2021 Filed Dec 7, 2021 22:40 UTC | BioAtla, Inc. BCAB · Entity 879 | SaleCommon Stock | 13,539 | $23.27 | $314,998.37 |
DisclosureSEC source: 0001209191-21-068383 · doc4.xml · nonDerivative · entry 5 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,328,575 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F6 · price: The range of prices for the shares of Common Stock is from $22.79 to $23.77. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| December 01, 2021 Filed Dec 7, 2021 22:40 UTC | BioAtla, Inc. BCAB · Entity 879 | SaleCommon Stock | 7,829 | $22.19 | $173,694.19 |
DisclosureSEC source: 0001209191-21-068383 · doc4.xml · nonDerivative · entry 4 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,342,114 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F5 · price: The range of prices for the shares of Common Stock is from $21.79 to $22.73. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| November 30, 2021 Filed Dec 7, 2021 22:40 UTC | BioAtla, Inc. BCAB · Entity 879 | SaleCommon Stock | 2,845 | $25.38 | $72,203.26 |
DisclosureSEC source: 0001209191-21-068383 · doc4.xml · nonDerivative · entry 3 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,349,943 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F4 · price: The range of prices for the shares of Common Stock is from $25.30 to $25.38. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| November 30, 2021 Filed Dec 7, 2021 22:40 UTC | BioAtla, Inc. BCAB · Entity 879 | SaleCommon Stock | 8,126 | $24.68 | $200,517.18 |
DisclosureSEC source: 0001209191-21-068383 · doc4.xml · nonDerivative · entry 2 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,352,788 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F3 · price: The range of prices for the shares of Common Stock is from $24.33 to $25.25. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| November 30, 2021 Filed Dec 7, 2021 22:40 UTC | BioAtla, Inc. BCAB · Entity 879 | SaleCommon Stock | 7,519 | $24.00 | $180,433.44 |
DisclosureSEC source: 0001209191-21-068383 · doc4.xml · nonDerivative · entry 1 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,360,914 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F2 · price: The range of prices for the shares of Common Stock is from $23.33 to $24.32. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| November 29, 2021 Filed Dec 7, 2021 01:41 UTC | BioAtla, Inc. BCAB · Entity 879 | SaleCommon Stock | 15,435 | $23.89 | $368,742.15 |
DisclosureSEC source: 0001209191-21-068210 · doc4.xml · nonDerivative · entry 1 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,368,433 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F2 · price: The range of prices for the shares of Common Stock is from $23.75 to $24.11. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.